Recent news highlights the importance of regulatory compliance for pet
Recent news highlights the importance of regulatory compliance for pet supplements. A federal agency has issued warnings to several companies that market products containing certain compounds derived from plants, as well as mushroom-based supplements for pets. The agency found that these companies were making therapeutic claims about their products, such as the ability to treat, prevent, or mitigate diseases in animals.
Under federal law, making such claims classifies the products as unapproved new animal drugs, which cannot be legally sold without an official application. Additionally, some products were deemed adulterated because the plant-derived compound is not an approved ingredient for animal food. The agency also raised concerns about food safety, especially for products intended for food-producing animals, due to a lack of research on potential residues and human safety.
In response, an industry trade group has urged its members to review the warning letters carefully and ensure their product claims align with regulatory guidelines. This action is crucial to maintaining the integrity and reputation of the pet supplement industry as a whole.
Source – Pet Food Industry
